AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2020
May 8, 2020
30016_dirs_2020-05-08_eead122d-a6ec-4188-bb60-ff04e9368111.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-05-06
Reporting Person: SZOSTAK M ANNE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-06 | Common Stock | G | 6717 | — | Disposed | 0 | Indirect |
| 2020-05-06 | Common Stock | G | 584 | — | Disposed | 0 | Direct |
| 2020-05-06 | Common Stock | G | 7301 | — | Acquired | 10217 | Indirect |
| 2020-05-06 | Common Stock | G | 10217 | — | Disposed | 0 | Indirect |
| 2020-05-06 | Common Stock | G | 10217 | — | Acquired | 10217 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-06 | Deferred Stock Unit | $ | A | 370 | Acquired | Common Stock (370) | Direct | |
| 2020-05-06 | Non-Qualified Stock Option (right-to-buy) | $283.59 | A | 1279 | Acquired | 2030-05-05 | Common Stock (1279) | Direct |
Footnotes
F1: The reporting person is the settlor of the M. Anne Szostak Trust ("Trust"), the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.
F2: The reporting person is the settlor and trustee of the 2020 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
F3: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
F4: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier.
F5: Not applicable.